New eye scan could Fine-Tune treatment timing for wet AMD

NCT ID NCT02868086

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at two ways of monitoring wet age-related macular degeneration (AMD) using eye scans: standard OCT B-scans and a newer technique called OCT angiography. The goal was to see if the newer scan could better detect when the disease is active, helping doctors decide when to give anti-VEGF injections. Sixty-eight adults with wet AMD were followed to compare how each scan affected treatment timing and vision stability.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If OCT angiography proves better at detecting when wet AMD is active, it could help doctors time anti-VEGF injections more precisely, potentially preserving vision with fewer visits.
What could go wrong
This is a small, completed study (68 people) comparing imaging techniques, not testing a new treatment. The results may not change current practice or improve vision outcomes significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondation Ophtalmologique A. de Rotchschild

    Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.